FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches

Clinical development success rates for investigational drugs

Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536

Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412

Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164 · cited 1×

Believe it or not: how much can we rely on published data on potential drug targets?

Prinz, F., Schlange, T., & Asadullah, K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439-c1 · Cited by 1,888

An analysis of the attrition of drug candidates from four major pharmaceutical companies

Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4609 · Cited by 1,450

Personalized medicine: Time for one-person trials

Schork, N. J. (2015) · Nature · doi:10.1038/520609a · Cited by 1,274

The economics of reproducibility in preclinical research

Freedman, L. P., Cockburn, I. M., & Simcoe, T. S. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002165 · Cited by 1,055

Organs-on-chips: into the next decade

Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P., & Tagle, D. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0079-3 · Cited by 1,029 · cited 1×

Genealogies of mouse inbred strains

Beck, J. A., Lloyd, S. E., Hafezparast, M., Lennon-Pierce, M., Eppig, J. T., Festing, M. F. W., & Fisher, E. (2000) · Nature Genetics · doi:10.1038/71641 · Cited by 825

Trends in clinical success rates and therapeutic focus

Dowden, H., & Munro, J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/d41573-019-00074-z · Cited by 649 · cited 1×

Shifting machine learning for healthcare from development to deployment and from models to data

Zhang, A., Xing, L., Zou, J., & Wu, J. C. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00898-y · Cited by 420

Bridging the Translational Gap: Rethinking Smooth Muscle Cell Plasticity in Atherosclerosis Through Human-Relevant In Vitro Models

Som, L., & Smart, N. (2025) · Cells · doi:10.3390/cells14231913 · Cited by 8

The Promise of Animal Testing Alternatives at the U.S. Food and Drug Administration and National Institutes of Health

Tieghi, R. S., Høeg, T. B., Makary, M. A., & Kleinstreuer, N. (2025) · NEJM AI · doi:10.1056/aipc2500587 · Cited by 7

Deep Learning‐Powered Scalable Cancer Organ Chip for Cancer Precision Medicine

Yuan, Y. S., Xu, B., McCormack, J., Huang, X., Ma, J., Marshall, T., Sun, Y., Singh, H., Fanelli, A., Kulkarni, G., et al. (2026) · Advanced Science · doi:10.1002/advs.202516660 · Cited by 13

Stem Cell-Derived Organoids for Cancer Therapy: Precision Medicine and Drug Selection

Azim, M. M. N., Bhajan, S. K., Park, J. H., Abass, K. S., Rahman, A., Choi, M., Choi, J., Park, S., Kim, H. J., Akter, S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27072954 · Cited by 7

From Promise to Practice: Recent Growth in 30 Years of Tissue Engineering Commercialization

Felix, R. B., Shabazz, A., Holeman, W. P., Han, S., Wyble, M., Uzoukwu, M., Gomes, L. A., Nho, L., Litman, M. Z., Hu, P., et al. (2024) · Tissue Engineering Part A · doi:10.1089/ten.tea.2024.0112 · Cited by 7

Targeting Protein Aggregation in ALS

Perni, M., & Mannini, B. (2024) · Biomolecules · doi:10.3390/biom14101324 · Cited by 8

Safety and implementation of phase I randomized GLA-SE–adjuvanted CH505TF gp120 HIV vaccine trial in newborns

Violari, A., Otwombe, K. N., Hahn, W. O., Chen, S., Josipovic, D., Baba, V., Angelidou, A., Smolen, K. K., Levy, O., Mkhize, N. N., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186927 · Cited by 8

Preclinical modeling of metabolic syndrome to study the pleiotropic effects of novel antidiabetic therapy independent of obesity

Mochel, J. P., Ward, J. L., Blondel, T., Kundu, D., Merodio, M. M., Zemirline, C., Guillot, E., Giebelhaus, R. T., de la Mata, A. P., Iennarella‐Servantez, C. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-71202-y · Cited by 10

Digital Light Processing 3D Printing enables High Throughput Fabrication of Human Engineered Heart Tissues for Disease ModelingPreprint

Dhand, A. P., Juarros, M. A., Martin, T. G., Rodriguez‐Rivera, G. J., Hunt, D. R., Obenreder, M. C., Crosby, C. O., Meurer-Zeman, B., Mcafee, Q. W., Valle-Ayala, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.01.616163 · Cited by 7

Tumor organoids: A review of culture methods, applications in cancer research, precision medicine, and drug development

Chang, C., Tsai, C.-C., Cheng, C., Chu, T.-Y., Chiang, C., Lee, Y., Wu, C., Chen, J., Kuo, C., & Hsu, P.-C. (2025) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_256_24 · Cited by 6

-Omics approaches to study and model cell-cell interactions in engineered tissues

Stark, C., Jenison, S. E., & Ngo, M. T. (2025) · Frontiers in Chemical Engineering · doi:10.3389/fceng.2025.1629455 · Cited by 7

Organoids in cancer therapy: translational applications and clinical promise

Bai, M., Liu, M., Wang, S., Ran, M., Ye, J., 薛玉芹, Zhang, C., Wang, Y., Lu, J., Dai, F., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02678-7 · Cited by 6

Are we ready to integrate 3D culture systems in acute myeloid leukemia and bone marrow microenvironment research?

Sharipol, A., & Frisch, B. J. (2024) · Frontiers in Hematology · doi:10.3389/frhem.2024.1407698 · Cited by 7

Functional genomics in age-related macular degeneration: From genetic associations to understanding disease mechanisms

Ratnapriya, R., Grassman, F., Chen, R., Hewitt, A. W., Du, J., Saban, D. R., Klaver, C. C. W., Ash, J. D., Stambolian, D., Tumminia, S. J., et al. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110344 · Cited by 6

AI-Assisted Label-Free Monitoring Bone Mineral Metabolism on Demineralized Bone Paper

Ryan, P. P., Yoon, H., Amin, S., Chambers, J. J., & Lee, J. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c02349 · Cited by 6

Engineered Tissue Models to Decode Host–Microbiota Interactions

Adelfio, M., Callen, G. E., He, X., Paster, B. J., Hastürk, H., & Ghezzi, C. E. (2025) · Advanced Science · doi:10.1002/advs.202417687 · Cited by 6

The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modeling

Juguilon, C., & Wu, J. C. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050947 · Cited by 6

Effects of esketamine on electrophysiology and metabolic reprogramming in brain organoids: insights into antidepressant mechanisms

Li, M., Duan, W., Hao, X., Li, S., Wang, C., Liang, Y., Hu, Z., Ma, D., Guo, M., Zuo, C., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03198-4 · Cited by 5

Nasal microbionts differentially colonize and elicit cytokines in human nasal epithelial organoids

Boyd, A. I., Kafer, L. A., Escapa, I. F., Kambal, A., Tariq, H., Hilsenbeck, S. G., Nguyen‐Phuc, H., Rajan, A., Lensmire, J. M., Patras, K. A., et al. (2025) · mSphere · doi:10.1128/msphere.00493-25 · Cited by 6

Adenosine receptors on the immuno-oncology expressway: TIME, perspectives, and translation

Majumder, B., & Datta, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1676702 · Cited by 6

Predicting human pharmacokinetic parameters of drugs using a multi-tissue chip platform integrating liver, kidney, and skeletal muscle microphysiological systems

Sherfey, J. S., Rajan, S. A. P., Nichols, L. M., Parekh, P., Smith, J. T., Gregory, L., Clark, F., Kadar, E. P., Ohri, S., George, B. T., et al. (2026) · Lab on a Chip · doi:10.1039/d6lc00008h · Cited by 5

Integration of electrochemical sensors in organ-on-a-chip microfluidic platforms: Advances and perspectives

Casanova, A., Alimohammadzadeh, E., McCormirk, S., Thomas, Y. R. J., den Dulk, R., Baldi, A., Fernández‐Sánchez, C., Ghaemmaghami, A. M., & Mailley, P. (2026) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2026.118981 · Cited by 5

3D-printed β-TCP scaffold as a bone-mimicking environment for an engineered model of osteosarcoma: In vitro properties and transcriptomic insights

Menshikh, K. A., Gobbo, V. A., Nascimben, M., Hannula, M., Cochis, A., Serra, T., Massera, J., Pandit, A. S., & Rimondini, L. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101766 · Cited by 5

A Human Engineered Heart Tissue‐Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin

Cai, L., Zhao, Y., Li, Z., Xiao, L., Wu, Y., Wang, S., Liu, Q., Ye, Y., Guo, Y., & Zhang, D. (2025) · Advanced Science · doi:10.1002/advs.202503173 · Cited by 6

Innovative micro physiological systems for vaccine development

Reynaud, K., Atwell, S. X., Védrine, C., Guyard, C., & Belœil, L. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2518641 · Cited by 5

Bioengineered Models of Nerve Regeneration

Thompson, M. J., & Frampton, J. P. (2025) · Advanced Materials Technologies · doi:10.1002/admt.202402062 · Cited by 5

Harnessing organoid technology in urological cancer: advances and applications in urinary system tumors

Wang, X., Lin, D., & Feng, N. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-03948-2 · Cited by 5

Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkers

Diray‐Arce, J., Chang, A. C., Moradipoor, S., Amodio, D., Carleton, B., Chang, W., Crawford, N. W., Karoly, M., Hoch, A., McEnaney, K., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127504 · Cited by 5

Decoding Pain: Next‐Generation In Vitro Systems for Mechanistic Insights and Drug Discovery

Khosrowshahi, D., Lagae, L., & Bolander, J. (2025) · The FASEB Journal · doi:10.1096/fj.202501025rr · Cited by 5

Optimal dosing of anti-cancer treatment under drug-induced plasticity

Gunnarsson, E. B., Magnússon, B. V., & Foo, J. (2025) · npj Systems Biology and Applications · doi:10.1038/s41540-025-00571-5 · Cited by 6

The role for artificial intelligence in identifying combination therapies for Alzheimer’s disease

Cheng, F., Sha, Z., Zhou, Y., Hou, Y., Zhang, P., Pieper, A. A., & Cummings, J. L. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100366 · Cited by 6

GD2-CAR–Engineered Microglia Exhibit Antitumor Effects in Organoids and Animal Models of Retinoblastoma

Xu, J., Gao, Y., Wang, J., Lyv, M., Zhang, Z., Cheng, Y., & Jin, Z. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.14.26 · Cited by 5

Initiation of primary T cell—B cell interactions and early antibody responses in an organized microphysiological model of the human lymph nodePreprint

Raskovic, D., Zatorski, J. M., Arneja, A., Kiridena, S., Ozulumba, T., Hammel, J. H., Anbaei, P., Ortiz-Cárdenas, J. E., Braciale, T. J., Munson, J. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.12.632545 · Cited by 5

Vaccinology: Getting our modernization act together

Levy, O. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20240961 · Cited by 4

Can alternatives to animal testing yield useful information regarding biological mechanisms and drug discovery?

Gao, Q., Chow, S. K., Shinohara, I., Murayama, M., Susuki, Y., Morita, M., Ma, C., & Goodman, S. B. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2025.08.005 · Cited by 4

Organoids and organ‐on‐a‐chip models for investigating the pathophysiology of the human reproductive system

Zhang, H.-B., Deng, S., Jin, F. G., Qu, J., Fan, X., Chen, P., & Fan, X. (2026) · Interdisciplinary medicine · doi:10.1002/inmd.70094 · Cited by 4

The Synthetic Extracellular Matrix as a Maestro of the In Vitro Stem Cell Niche: Orchestrating Fate and Function

Giri, S., & Rajesh, P. (2026) · Biomedicines · doi:10.3390/biomedicines14020485 · Cited by 5

Multiple organ dysfunction syndrome: molecular mechanisms and therapeutic strategies

Xu, X., Chen, J., Feng, Y., Zou, C., Peng, X., Wang, Z., Ma, Y. X., Xie, Y., Li, H., & Zhang, D. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02782-6 · Cited by 4

Need for NAMs: A systematic evidence synthesis revealing over half a century of drug development failure

Filipova, D., Boomgaarden, W., Fox, L., Knight, A., Lickiss, B., Maaß, C., Neumann, G., Watkins, J. C., Herrmann, K., Ewart, L., et al. (2026) · NAM journal. · doi:10.1016/j.namjnl.2026.100119 · Cited by 4

In vitro models for neuropathic pain phenotypic screening in brain therapeutics

Martínez, A. L., Brea, J. M., López, D., Cosme, N., Barro, M., Monroy, X., Burgueño, J., Merlos, M., & Loza, M. I. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107111 · Cited by 4

Real-time and regional analysis of the efficacy of anticancer drugs in a patient-derived intratumoral heterogeneous tumor microenvironment

Lin, Y., Lin, C.-M., Man, K., Hung, C., Hsu, H.-L., Chen, Y., Mu, H., Hsiao, T., & Huang, J. (2025) · Lab on a Chip · doi:10.1039/d4lc00990h · Cited by 4

The advancements in organoids: Potential and challenges in researching the esophagus and esophageal squamous cell carcinoma

Li, X., Wang, Z., Liu, Y., Zhang, J., Zhang, L., Li, Y., An, X., Yang, Y., Yu, R., Zhao, M., et al. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101680 · Cited by 4

Nearness by design: modeling brains with organoids

Hogle, L. F. (2025) · BioSocieties · doi:10.1057/s41292-025-00352-7 · Cited by 4

Stimulation of α7 Nicotinic Acetylcholine Receptors by PNU282987 Demonstrates Efferocytosis-Like Activation and Neuroprotection in Human Models of Microglia and Cholinergic Neurons under the Pathophysiological Conditions of Alzheimer’s Disease

Sueyoshi, M., Harada, K., Okawa, M., Matsuhara, T., Ando, M., Araki, R., Minote, Y., Ishihara, K., Shimohama, S., & Takata, K. (2025) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b25-00308 · Cited by 4

Liver Organoid and Liver‐On‐A‐Chip Platforms for Modeling Alcoholic Liver Disease: A Comparative Review

Chen, Q., Li, C., Ding, W., & Kong, D. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503273 · Cited by 5

Human organoids: Fit for drug discovery?

Wittich, A., Krieg, K., Gribbon, P. M., Metzger, J. J., Prigione, A., & Pleß, O. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.102898 · Cited by 4

Evolution of toxicity testing platforms from 2D to advanced 3D bioprinting for safety assessment of drugs

Shyam, R., Singh, R., Bajpai, M., Palaniappan, A., & Parthasarathi, R. (2024) · Bioprinting · doi:10.1016/j.bprint.2024.e00363 · Cited by 4

Emerging supramolecular and living materials in oral medicine

Fischer, N. G., Lin, T.-Y., Xiang, Y., Sang, T., & Ye, Z. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.03.006 · Cited by 4

AI-driven microscopy: from classical analysis to deep learning applications

Bhattiprolu, S. (2025) · Methods in microscopy · doi:10.1515/mim-2024-0033 · Cited by 4

Combining Scalable Organ Chip Platform with Deep Learning-Based Imaging Analysis for Cancer Therapeutic ScreeningPreprint

Yuan, Y., Xu, B., McCormack, J., Huang, X., Ma, J., Marshall, T., Sun, Y., Singh, H., Fanelli, A., Gilbride, P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.10.598272 · Cited by 4

From Policy to Practice: Advancing Environmental Toxicology through New Approach Methodologies

Wang, H., Xu, T., & Yin, D. (2025) · Environment & Health · doi:10.1021/envhealth.5c00323 · Cited by 4

Organoids, organs-on-chips, complex in vitro model: Definitions, applications, validation, ethics

Mottet, G., Grassart, A., Barthélemy, P., Antignac, C., Arrabal, S., BOURDIN, A. A., Descroix, S., Vos, J. D., Doutriaux, A., Fabrega, Q., et al. (2024) · Therapies · doi:10.1016/j.therap.2024.12.002 · Cited by 3

A High‐Throughput AngioPlate Platform with Integrated AngioTEER for Modeling and Monitoring Renal Proximal Tubule Injury

Rajasekar, S., Chakravarty, A., Jozani, K. A., Truong, B., Hendrickson, M., Attia, A., Sabouny, M., Basatskaya, A., Clotet‐Freixas, S., Ludlow, M., et al. (2025) · Advanced Materials Technologies · doi:10.1002/admt.202500658 · Cited by 3

Integral approach to organelle profiling in human iPSC-derived cardiomyocytes enhances in vitro cardiac safety classification of known cardiotoxic compounds

Szabo, B. R., Stein, J. M., Savchenko, A. S., Hutschalik, T., Nieuwerburgh, F. V., Meese, T., Kosmidis, G., Volders, P. G. A., & Matsa, E. (2025) · Frontiers in Toxicology · doi:10.3389/ftox.2025.1644119 · Cited by 3

Natural products, artificial intelligence, and the future of anti-aging pharmacology: A human-centered call to action

Lee, C. H., & Lee, S. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107952 · Cited by 3

Attenuation of blood-brain barrier dysfunction by functionalized gold nanoparticles against amyloid-β peptide in an Alzheimer's disease-on-a-chip model

Tapia-Arellano, A., Palma-Florez, S., Cabrera, P., Cortés-Adasme, E., Bolaños, K., Célis, F., Araya-Vergara, A. J., Pérez, M., Crespo, A., Matus, M. H., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102453 · Cited by 4

Applications and Complementarity of Organ‐Chips and Animal Models in Lung Cancer Driver Gene Research

Wang, L., Wu, T., & Tsai, F. (2025) · Cell Biology International · doi:10.1002/cbin.70108 · Cited by 3

Kidney Organoids in Drug Development: Integrating Technological Advances and Standardization for Effective Implementation

Kearney, H., Mihaila, S. M., Moroni, L., & Mota, C. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202504719 · Cited by 6

Bioengineered intestinal models: structural precision drives functional and microbial fidelity

Gao, Z., Du, H., Yu, S., Li, Q., Li, Y., Yin, J., Yang, H., Wang, Y., Zhou, H., & Shen, L. (2025) · Bio-Design and Manufacturing · doi:10.1631/bdm.2500353 · Cited by 3

Enabling the recirculation of leukocytes in a high-throughput microphysiological system (MPS) to study immune cell-vascular tissue interactions

Gerhardson, T., Haroutunian, N. J., Dubay, R., Urban, J. N., Quinnert, A., Isenberg, B. C., Kann, S. H., Kim, H., Gaibler, R. B., Azizgolshani, H., et al. (2026) · Lab on a Chip · doi:10.1039/d5lc01001b · Cited by 3

Advances in the pathophysiological study of brain development: application of cerebral organoid combined with Spatial omics technology

Wang, J., Sun, Z., Zhou, Y., Wang, L., & Liu, J. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04885-3 · Cited by 3

Photocrosslinkable lung dECM hydrogels promote stiffness-dependent lung cancer growth and chemoresistance

Hipwood, L., Dekker, M., Hutmacher, D. W., Meinert, C., & McGovern, J. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102838 · Cited by 4

Heterogeneity and optimal study design between cell lines in induced pluripotent stem cell-based cardiac disease modeling

Maas, R. G. C., Denning, C. N., & Sluijter, J. P. G. (2026) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szag001 · Cited by 4

A simplified co-culture reveals altered cardiotoxic responses to doxorubicin in hPSC-derived cardiomyocytes in the presence of endothelial cells

Brescia, M., Gallant, J., Chatrian, A., Keselman, P., Paulsson, E. S., Mol, M. P. H., Sjögren, R., Raymond, K., Orlova, V. V., Barnes, K., et al. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.102816 · Cited by 3

Digital light processing 3D printing enables versatile fabrication of human engineered heart tissues

Dhand, A. P., Juarros, M. A., Martin, T. G., Garay‐Sarmiento, M., Alamana, C., Hunt, D. R., Rodriguez‐Rivera, G. J., Obenreder, M. C., Crosby, C. O., Meurer-Zeman, B., et al. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100405 · Cited by 4

On-Chip modeling of drug-gut interactions in Oral drug delivery

Abdollahi, S., Vajhadin, F., Rafiei, A., Tamrin, S. H., Daniel, S. D., Banoei, M. M., Zarin, B., Sen, A., Kim, K., & Sanati‐Nezhad, A. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115864 · Cited by 3

Precision nose-to-brain therapeutics: Advances in drug delivery systems and emerging preclinical models

Lu, Y., Wei, G., Zhengle, Z., Xu, X., Huang, J., Zhou, J., Gu, X., Han, G., & Ding, Y. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114946 · Cited by 5

Shear Stress Modeling and Machine Learning for Nanomedicine Development: A Mechanistic Pathway to Pharmacokinetic Prediction

Modh, H., Leong, D., Dindhoria, K., Malinovskaya, J. A., Pirola, S., Wendt, B., & Wacker, M. G. (2026) · ACS Nano · doi:10.1021/acsnano.6c05350 · Cited by 3

Have plastic culture models prevented the discovery of effective cancer therapeutics?

Tharp, K. M. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17387 · Cited by 3

Comprehensive assessment of intradermal responses to hyaluronic acid-based skin injection fillers through multi-pathway dynamic synergies

Zhong, M., He, H., Wang, L., Pu, L., Liu, Z., Wang, J., Zhang, Y., Wang, S., Sun, B., Li, X., et al. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114378 · Cited by 3

Can We Use CAR-T Cells to Overcome Immunosuppression in Solid Tumours?

Gwadera, J., Grajewski, M., Chowaniec, H., Gucia, K., Michoń, J., Mikulicz, Z., Knast, M., Pujanek, P., Tołkacz, A., Murawa, A., et al. (2025) · Biology · doi:10.3390/biology14081035 · Cited by 3

Bioengineered Chip Model for Magnetic-Nanoparticle-Driven Targeted Cancer Therapy

Dhar, D., Manna, D., Laha, S., Pradhan, S., Bhattacharya, S., Mukherjee, B., Chatterjee, J., Das, S., & Chakraborty, S. K. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c13763 · Cited by 3

Deciphering Congenital Heart Disease Using Human Induced Pluripotent Stem Cells

Zhang, H., & Wu, J. C. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-44087-8_13 · Cited by 3

Evolution of biofabrication and 3D-bioprinting technologies – from market pull to technology push

Blaeser, A. (2024) · at - Automatisierungstechnik · doi:10.1515/auto-2024-0070 · Cited by 2

Engineered In Vitro Models to Improve the Mechanistic Understanding and Treatment of Neglected Tropical Diseases Caused by Protozoan Parasites

Monjure, T., Rosero, J., Ruley, J. A., Hernandez, A. J., Kima, P. E., & Porras, A. M. (2024) · GEN Biotechnology · doi:10.1089/genbio.2024.0020 · Cited by 2

Human intestinal enteroids: Nonclinical applications for predicting oral drug disposition, toxicity, and efficacy

O'Mahony, E. T., Arian, C. M., Aryeh, K. S., Wang, K., Thummel, K. E., & Kelly, E. J. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108879 · Cited by 2

Bioprinting of hydrogels

Palaniappan, A., Ramesh, P., Maya, B., & Shyam, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29260-6.00016-0 · Cited by 3

Pulsed electromagnetic field stimulation subtly modulates doxorubicin sensitivity in a spheroid co-culture model of osteosarcoma

Menshikh, K. A., Antonaci, M., Radini, V., Salati, S., Daou, F., Cochis, A., & Rimondini, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-26524-w · Cited by 2

Artificial intelligence in biomedical research: advancing non-animal methodologies

Sandhu, J. S., Parida, A., Hegde, S., & Manju, V. (2025) · Frontiers in Animal Science · doi:10.3389/fanim.2025.1687111 · Cited by 3

Appearance-based computer vision pipeline for multi-animal monitoring of canine activity, behavior and clinical observations

Eberhardt, E., Plochaet, J., Ophoff, T., Feyter, F. D., Landtsheer, S. D., Teuns, G., Vergauwen, M., Feyen, B., Goedemé, T., & Kopljar, I. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1758963 · Cited by 2

Recapitulating Alzheimer’s disease pathophysiology with a microfluidic neurospheroid-grafted endothelial barrier model

Uzoechi, S. C., Johnson-Campbell, C., Badeaux, C. J., Kwak, S. S., Kim, D. Y., & Yun, Y. (2026) · Molecular Brain · doi:10.1186/s13041-026-01285-3 · Cited by 2

Microfluidic engineering of immune-competent organs-on-chips and their applications

Liang, X., Bu, X., Yuan, S., Wu, C., Liu, D., & Deng, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1743806 · Cited by 2

Organoid models: Regulations and prospects for the development of investigational new drugs

Li, H., Pan, Y., Zheng, Z., Lin, R., Pan, Y., Lin, L., Quan, M., Lu, H., Hu, Z., Zheng, M., et al. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004067 · Cited by 4

Spatially resolved osteoblast-traced transcriptomics uncovers TGF-β as a combination target with sclerostin in osteoporosis

Choi, A., Lee, J. Y., Yoon, H., Che, X., Choi, M., Park, Y., Shin, K., Lee, H., Park, J., Kong, S. H., et al. (2026) · Bone Research · doi:10.1038/s41413-026-00521-9 · Cited by 2

Lipid nanoparticles for bone marrow-targeted RNA therapeutics

Casimiro, L. D. M., Escudero, R., Plessis, M. D., Schiffelers, R. M., & Heidenreich, O. T. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04423-0 · Cited by 2

End-to-end automation of organ-on-a-chip culture and drug testing: Enhancing scalability and expandability

Shibuta, M., Tetsuka, K., Kawabe, T., Namatame, I., Asano, H., Heijmans, J., Wevers, N. R., & Sasaki-Iwaoka, H. (2026) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2026.100434 · Cited by 2

Lung organoids for respiratory diseases: overcoming translational hurdles in drug discovery and safety assessment

Mao, X.-Y., Cai, M.-M., & Fan, B. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1859058 · Cited by 1

Recapitulating In Vivo Pharmacokinetics and Size‐Dependent Nanomedicine Delivery in a Microfluidic Platform

Kang, S. J., Yoon, M. S., Lee, J. M., Jo, M. J., Jin, C. E., & Shin, D. H. (2026) · Advanced Science · doi:10.1002/advs.77137 · Cited by 2

hPSC-Derived Astrocytes at the Forefront of Translational Applications in Neurological Disorders

Jovanovic, V. M., Mesch, K. T., & Tristan, C. A. (2024) · Cells · doi:10.3390/cells13110903 · Cited by 3

Automated In Vitro Wound Healing AssayPreprint

Cwycyshyn, J., Stansbury, C. M., Meixner, W., Hoying, J. B., Muir, L. A., & Rajapakse, I. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.23.573213 · Cited by 2

Renin-Angiotensin Aldosterone System Modulation and Cardiovascular-Kidney-Metabolic HealthPreprint

Mochel, J. P. (2024) · Preprints.org · doi:10.20944/preprints202406.2075.v1 · Cited by 1

Systems biology framework for rational design of operational conditions for in vitro / in vivo translation of microphysiological systemsPreprint

Cadavid, J. L., Meimetis, N., Matsuzaki, T., Tevonian, E. N., Griffith, L. G., & Lauffenburger, D. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.17.633624 · Cited by 2

Ex vivo recapitulation of intramuscular mRNA vaccination with naïve and recall antigens using a human Lymphoid Follicle Chip platformPreprint

Zhai, Y., Ku, M., Yang, K., Patil, A., Prabhala, P., He, L., Man, Y., Spörri, S. B., Gharpure, S., Isaacs, A. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.16.649172 · Cited by 2

In Silico Research Is Rewriting the Rules of Drug Development: Is It the End of Human Trials?

Lakhan, S. E. (2025) · Cureus · doi:10.7759/cureus.84007 · Cited by 4

Go with the flow: An in vitro model of a mature endothelium for the study of the bioresponse of IV injectable nanomedicines

Nikravesh, N., Rippl, A., Hoch, T., Eitner, S., Pai, A. B., Digigow, R. G., Chortarea, S., Diener, L., Ayala‐Nunez, V., & Wick, P. (2024) · Toxicology in Vitro · doi:10.1016/j.tiv.2024.105953 · Cited by 1

Patient-derived induced pluripotent stem cell organoids for amyotrophic lateral sclerosis drug discovery

Li, W., Liu, J., Li, W., Sun, L., Zhang, H., Gao, L., & Gao, C. (2025) · Acta Materia Medica · doi:10.15212/amm-2024-0077 · Cited by 1

Bioprinted 3-dimensional lung organoids for respiratory disease modeling and therapeutic applications

Jang, J., & Yang, S. (2025) · Organoid · doi:10.51335/organoid.2025.5.e8 · Cited by 1

Integrative and Emerging Models in Antibody Research: A Comprehensive Review

Devasani, J. R., Guntuku, G., sarabu, P., Muthyala, M. K. K., Palla, M. S., & Volety, M. S. (2025) · Antibody Therapeutics · doi:10.1093/abt/tbaf018 · Cited by 2

Promise of Quantitative Proteomics in the Qualification of New Approach Methodologies

Prasad, B. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70049 · Cited by 1

Quantitative assessment of nanoparticle uptake and trafficking in advanced 3D cell models: A high-content screening core to enhance precision nanomedicine development

Cutrona, M. B. (2025) · Methods in cell biology · doi:10.1016/bs.mcb.2025.10.002 · Cited by 1

AI-powered organoids and organ chips: Advancing human-specific models for biomedical research

Lu, X., He, J., Zhang, H., Qu, Y., & Han, X. (2026) · The Innovation Medicine · doi:10.59717/j.xinn-med.2026.100186

“Humanized” Large Animal Cancer Models: Accelerating Time and Effectiveness of Clinical Trials

(2019) · Frontiers research topics · doi:10.3389/978-2-88963-249-7

The development of a humanized animal model

van Goor, H., Gouw, A. S. H., & Visser, A. (2005)

[Research] Milestone! FDA Advances Organoid Technology to Replace Animal Testing

Miles, L. (2025) · doi:10.13140/rg.2.2.30064.98565

A Novel Humanized Animal Model for Experimental Medicine

Katsuki, M. (1995) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)35549-0